New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer

Guopei Luo(Fudan University Shanghai Cancer Center), Xianjun Yu(Fudan University Shanghai Cancer Center), Jiang Long(Shanghai Medical College of Fudan University), Meng Guo(Fudan University), Kun Fan(Shanghai Medical College of Fudan University), Jin Xu(Fudan University Shanghai Cancer Center), Qiuyi Huang(Shanghai Medical College of Fudan University), Renquan Lu(Shanghai Medical College of Fudan University), Lu Yu(Shanghai Medical College of Fudan University), Zhiyao Fan(Shanghai Medical College of Fudan University), Chen Liu(Hubei Provincial Women and Children's Hospital), Cheng He(Ministry of Natural Resources), Liang Liu(Dongyang University), Kaizhou Jin(Shanghai Medical College of Fudan University), Chao Yang(The Fifth People's Hospital of Anyang), Quanxing Ni(Shanghai Medical College of Fudan University), Andrew L. Warshaw(Harvard University)
Pancreatology
August 9, 2018
Cited by 79


Related Papers